Mukherjee T

ORCID: 0000-0002-6359-653X · 6 papers in corpus · active 1996-2024

Study types

  • article 2
  • rct 1

Condition tags

  • endometriosis 3
2024
The role of extracellular vesicles in the pathogenesis of gynecological cancer.
Frontiers in oncology ·doi:10.3389/fonc.2024.1477610

Gynecological cancer, the most common form of cancers in women worldwide, initiates in the reproductive organs of females. More often, the common treatment measures, i.e. surgery, radiation, and medical oncology are found to be unsuccessful…

2023
Beyond Macromolecules: Extracellular Vesicles as Regulators of Inflammatory Diseases.
Cells ·doi:10.3390/cells12151963

Inflammation is the defense mechanism of the immune system against harmful stimuli such as pathogens, toxic compounds, damaged cells, radiation, etc., and is characterized by tissue redness, swelling, heat generation, pain, and loss of tiss…

2015
Maximum basal FSH predicts reproductive outcome better than cycle-specific basal FSH levels: waiting for a "better" month conveys limited retrieval benefits.
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-015-0078-0

BackgroundElevated follicle stimulating hormone (FSH) is associated with poor vaginal oocyte retrieval (VOR) outcomes and cycle cancellations but intercycle variability in basal FSH reportedly does not predict ovarian response.MethodsWe con…

article 2012
Ovarian endometriosis with co-existing granulomatous inflammation—a rare association
Medical journal, Armed Forces India ·doi:10.1016/s0377-1237(12)60028-8
article 1997
Endometriosis is not detrimental to embryo implantation in oocyte recipients
Journal of assisted reproduction and genetics ·doi:10.1007/bf02766132

PurposeOur purpose was to determine the effects of endometriosis on implantation and pregnancy rates in ovum recipients.MethodsThe medical records of 239 consecutive oocyte recipient patients who were treated between January 1, 1991, and Ju…

rct 1996
A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment
American Journal of Obstetrics and Gynecology ·doi:10.1016/s0002-9378(96)70258-2

OBJECTIVE: Our purpose was to determine whether intermittent cyclic etidronate therapy blocks the decline in bone density associated with gonadotropin-releasing hormone agonist therapy. STUDY DESIGN: Thirty-one premenopausal subjects who n…